COVID-19 in vulnerable populations, its long-term effect, and the effectiveness of remdesivir

Projects lasting up to 9 months should collect data on the clinical course and outcome of COVID-19 in vulnerable populations, investigate long-term consequences of COVID-19 in patients, or test the safety and effectiveness of remdesivir in treating the disease.

Amount
Up to $250,000 USD
Agency or Funder
GILEAD
Foreign participation? (where known)
Yes
Keywords
Therapeutics
Clinical Studies
Vulnerable Groups
Pathogenesis
Country
US
Link(s) to announcement or call
https://www.gilead.com/science-and-medicine/research/investigator-sponsored-res…
Date of announcement
Date application deadline
View more opportunities from US View more opportunities